Recombinant Human Uncharacterized protein C20orf141 (C20orf141)

What is C20orf141 and where is it located in the human genome?

C20orf141 (Chromosome 20 Open Reading Frame 141) is a protein-coding gene located on chromosome 20p13 in humans. The gene contains 3 exons and is found at the genomic coordinates NC_000020.11 (2814987..2815830) . It is identified with Gene ID 128653 and is also known as dJ860F19.4 . The gene encodes an uncharacterized protein that has been predicted to be located in the cell membrane, based on bioinformatic analyses . As of March 2025, this protein remains largely uncharacterized in terms of its specific biological functions, making it an interesting target for exploratory research.

How should recombinant C20orf141 protein be stored and handled in the laboratory?

For optimal stability and activity, recombinant C20orf141 protein should be stored at -20°C for regular use, or at -80°C for extended storage periods . The recommended storage buffer typically contains Tris-based components with 50% glycerol, which is optimized for this specific protein .

When working with the protein, consider these handling practices:

• Avoid repeated freeze-thaw cycles as they can compromise protein integrity and activity

• For short-term use (up to one week), store working aliquots at 4°C

• Before each experiment, briefly centrifuge the protein vial after thawing to ensure all material is collected at the bottom

• Consider preparing multiple small aliquots upon first thawing to minimize freeze-thaw damage

What expression systems are available for producing recombinant C20orf141?

Recombinant C20orf141 can be produced using various expression systems, each with distinct advantages depending on research requirements:

The recombinant protein is typically produced with purity levels exceeding 80% as determined by SDS-PAGE and can be validated using techniques such as Western blotting and analytical SEC (HPLC) .

What experimental designs are most effective for studying uncharacterized proteins like C20orf141?

When designing experiments to investigate uncharacterized proteins like C20orf141, a systematic approach with appropriate time-point selection is critical. Research shows that human intuition often leads to sub-optimal experimental design decisions, particularly when selecting sampling time points . Computer-aided experimental design strategies can significantly improve the information yield of experiments.

For time-series experiments investigating protein function or expression patterns:

• Begin with pilot experiments using high-density time sampling to identify periods of dynamic activity

• Use statistical approaches to select optimal time points that maximize information capture while minimizing experimental costs

• Consider these key factors when designing follow-up experiments:

  • The variance of the function at different time points

  • The probability distribution of potential parameter values

  • The relationship between control and experimental conditions

For C20orf141 specifically, given its association with white matter integrity and potential role in bipolar disorder risk , longitudinal studies with carefully selected time points during neural development or disease progression would be particularly valuable.

How can protein-protein interaction networks be used to infer the function of C20orf141?

Protein-protein interaction (PPI) networks provide valuable insights into the potential functions of uncharacterized proteins through guilt-by-association principles. For C20orf141, researchers should:

• Perform co-immunoprecipitation followed by mass spectrometry to identify direct binding partners

• Use proximity labeling techniques (BioID or APEX) to map the local interaction environment

• Apply network analysis to identify hub genes most likely to interact with C20orf141

Recent studies using PPI approaches have successfully identified hub genes in complex biological processes. For example, in a study of slow versus fast death types, hub genes including TLR4, IGF1, PPARG, MMP2, TLR2, CCND1, COL1A1, VWF, and PECAM1 were identified in a network of 451 genes connected by 1,892 edges (p-value <1.0e-16) . Similar methodologies could be applied to understand C20orf141's functional networks.

What approaches can help elucidate the potential role of C20orf141 in white matter integrity and bipolar disorder risk?

Given the association of C20orf141 with white matter integrity as an intermediate phenotype in individuals at high risk of bipolar disorder , several strategic approaches can be employed:

• Genotype-Phenotype Correlation Studies:

  • Clean genotype data by identifying and addressing pedigree and genotyping errors, which are crucial prerequisites to genome scan analysis

  • Calculate likelihood ratios for various relationship types using markers on autosomes, adopting methods similar to those described by Boehnke and Cox

• Transcriptomic Analysis:

  • Compare gene expression profiles between affected and unaffected individuals

  • Identify differentially expressed genes (DEGs) using stringent statistical criteria (e.g., adjusted p-value using Bonferroni method < 0.01)

  • Construct protein-protein interaction networks to identify potential functional connections

• Pathway Analysis:

  • Investigate cellular pathways potentially affected by C20orf141 variations

  • Recent studies have shown that genes involved in extracellular matrix organization, collagen metabolic processes, and antigen processing/presentation can be differentially regulated in various conditions

What considerations are important when designing CRISPR-Cas9 knockout experiments for C20orf141?

When designing CRISPR-Cas9 knockout experiments for C20orf141, researchers should consider:

• Guide RNA Design:

  • Target exon regions that are critical for protein function

  • C20orf141 has 3 exons , so targeting early exons will maximize disruption probability

  • Use multiple guide RNAs to increase knockout efficiency

  • Avoid regions with high homology to other genomic locations

• Validation Strategy:

  • Confirm knockout at genomic level (sequencing)

  • Verify protein absence using Western blot with validated antibodies

  • Assess cellular phenotypes in multiple independent knockout clones

• Functional Rescue Experiments:

  • Reintroduce wild-type C20orf141 to confirm phenotype reversibility

  • Consider introducing mutated versions to identify critical functional domains

• Cell Type Selection:

  • Use cell types relevant to membrane proteins and/or neural function

  • Consider potential differences between in vitro and in vivo phenotypes

What quality control measures should be implemented when working with recombinant C20orf141?

Implementing rigorous quality control measures is essential when working with recombinant C20orf141:

• Purity Assessment:

  • SDS-PAGE with Coomassie blue staining (target >80% purity)

  • Western blot with specific antibodies against the protein or tag

  • Analytical size exclusion chromatography (SEC) via HPLC

• Functional Validation:

  • Verify folding using circular dichroism (CD) spectroscopy

  • Assess membrane integration potential using liposome association assays

  • For tagged proteins, confirm tag accessibility via immunoprecipitation

• Stability Monitoring:

  • Test protein stability under various storage conditions

  • Monitor degradation over time using SDS-PAGE

  • Develop functional assays specific to predicted protein activities

• Contaminant Testing:

  • Endotoxin testing for proteins expressed in bacterial systems

  • Mycoplasma testing for mammalian expression systems

  • Host cell protein (HCP) analysis using mass spectrometry

How can researchers optimize time point selection for experiments involving C20orf141?

Optimal time point selection is crucial for capturing meaningful data in experiments involving temporal dynamics. For C20orf141 research:

What bioinformatic approaches can predict functional domains in C20orf141?

For predicting functional domains in uncharacterized proteins like C20orf141, several complementary bioinformatic approaches should be employed:

• Sequence-Based Predictions:

  • Run the protein sequence through PFAM, SMART, and InterPro to identify conserved domains

  • Use transmembrane prediction tools (TMHMM, Phobius) to identify potential membrane-spanning regions

  • Apply signal peptide prediction (SignalP) to assess secretion potential

• Structural Predictions:

  • Generate 3D structure predictions using AlphaFold2 or RoseTTAFold

  • Identify potential binding pockets or active sites using cavity detection algorithms

  • Compare predicted structures with known proteins to infer function

• Evolutionary Analysis:

  • Perform multiple sequence alignment with orthologs across species

  • Identify conserved residues likely critical for function

  • Calculate selection pressure across different protein regions

• Integration with Experimental Data:

  • Correlate predictions with experimental findings from mutagenesis studies

  • Validate predicted functional sites using targeted techniques such as site-directed mutagenesis

  • Design experiments to test specific hypotheses generated from bioinformatic analyses